Omnicell Inc logo


Omnicell Inc


Earnings Summary

Net Profits
Net Profit Margins



Omnicell Inc’s revenue jumped 17.43% since last year same period to $348.06Mn in the Q3 2022. On a quarterly growth basis, Omnicell Inc has generated 5.03% jump in its revenue since last 3-months.

Net Profits:

Omnicell Inc’s net profit fell -42.78% since last year same period to $16.77Mn in the Q3 2022. On a quarterly growth basis, Omnicell Inc has generated 84.96% jump in its net profits since last 3-months.

Net Profit Margins:

Omnicell Inc’s net profit margin fell -51.28% since last year same period to 4.82% in the Q3 2022. On a quarterly growth basis, Omnicell Inc has generated 76.1% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Omnicell Inc post its latest quarter earnings

EPS Estimate Current Quarter
EPS Estimate Current Year


EPS Estimate Current Quarter:

Omnicell Inc’s earning per share (EPS) estimates for the current quarter stand at 0.1 - a -89.47% fall from last quarter’s estimates.

EPS Estimate Current Year:

Omnicell Inc’s earning per share (EPS) estimates for the current year stand at 0.1.

Key Ratios

Key ratios of the Omnicell Inc post its Q4 2022 earnings

Return on Assets (ROA)
Return on Equity (ROE)


Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Omnicell Inc’s return on assets (ROA) stands at 0.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Omnicell Inc’s return on equity (ROE) stands at 0.01.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %

Company Information

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

Omnicell Inc
590 East Middlefield Road, Mountain View, CA, United States, 94043
Technology Services
Randall Lipps

Trading and brokerage services provided by

Alpaca iconDrivewealth icon

Banking and Remittance services provided by

SBM icon

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*